BRIEF-European regulators recommends approval of Gilead's new HIV treatment
April 29, 2016 at 07:32 AM EDT
* EU Medicines Agency recommends approval of Biogen Inc and AbbVie Inc's daclizumab to treat multiple sclerosis
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.